Importance of Functional EGF Receptors in Recovery from Acute Nephrotoxic Injury

Journal of the American Society of Nephrology

Volumn 14, Issue 12, 2003, Pages 3147-3154

  Wang, Zoufei ^a   Chen, Jian Kang ^a   Wang, Su Wan ^a   Moeckel, Gilbert ^a   Harris, Raymond C ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENZYME ACTIVITY; GENE CONTROL; MOUSE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; WILD TYPE;

EID: 0344236403     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000098681.56240.1A     Document Type: Article

References (46)

1. Bonventre JV: Pathogenetic and regenerative mechanisms in acute tubular necrosis. Kidney Blood Press Res 21: 226-229, 1998
2. Harris RC: Growth factors and cytokines in acute renal failure. Adv Ren Replace Ther 4: 43-53, 1997
3. Toback FG: Regeneration after acute tubular necrosis. Kidney Int 41: 226-246, 1992
4. Hise MK, Salmanullah M, Liu L, Drachenberg CI, Papadimitriou JC, Rohan RM: Control of the epidermal growth factor receptor and its ligands during renal injury. Nephron 88: 71-79, 2001
5. Homma T, Sakai M, Cheng HF, Yasuda T, Coffey RJ Jr, Harris RC: Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J Clin Invest 96: 1018-1025, 1995
6. Sakai M, Zhang M, Homma T, Garrick B, Abraham JA, McKanna JA, Harris RC: Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules. J Clin Invest 99: 2128-2138, 1997
7. Yano T, Yazima S, Hagiwara K, Ozasa H, Ishizuka S, Horikawa S: Activation of epidermal growth factor receptor in the early phase after renal ischemia-reperfusion in rat. Nephron 81: 230-233, 1999
8. Lin JJ, Cybulsky AV, Goodyer PR, Fine RN, Kaskel FJ: Insulin-like growth factor-1 enhances epidermal growth factor receptor activation and renal tubular cell regeneration in postischemic acute renal failure. J Lab Clin Med 125: 724-733, 1995
9. Humes HD, Cieslinski DA, Coimbra T, Messana J, Calvao C: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84: 1757-1765, 1989
10. Norman JT, Tsau YK, Bacay A, Fine LG: Epidermal growth factor accelerates functional recovery from ischaemic acute tubular necrosis in the rat: Role of the epidermal growth factor receptor. Clin Sci 78: 445-450, 1990
11. Miller SB, Martin DR, Kissane J, Hammerman MR: Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci U S A 89: 11876-11880, 1992
12. Fowler KJ, Walker F, Alexander W, Hibbs ML, Nice EC, Bohmer RM, Mann GB, Thumwood C, Maglitto R, Danks JA, et al.: A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc Natl Acad Sci U S A 92: 1465-1469, 1995
13. Luetteke NC, Phillips HK, Qiu TH, Copeland NG, Earp HS, Jenkins NA, Lee DC: The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 8: 399-413, 1994
14. Roberts R, Min L, Washington M, Olsen S, Settle SH, Coffey RJ, Threadgill DW: Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Proc Natl Acad Sci U S A 99: 1521-1526, 2002
15. McKanna JA, Chuncharunee A, Munger KA, Breyer JA, Cohen S, Harris RC: Localization of p35 (annexin I, lipocortin I) in normal adult rat kidney and during recovery from ischemia. J Cell Physiol 153: 467-476, 1992
16. Miyaji T, Hu X, Star R: α-Melanocyte-simulating hormone and interleukin-10 do not protect the kidney against mercuric chloride-induced injury. Am J Physiol Renal Physiol 282: F795-F801, 2002
17. Satoh M, Nishimura N, Kanayama Y, Naganuma A, Suzuki T, Tohyama C: Enhanced renal toxicity by inorganic mercury in metallothionein-null mice. J Pharmacol Exp Ther 283: 1529-1533, 1997
18. Tanaka-Kagawa T, Suzuki M, Naganuma A, Yamanaka N, Imura N: strain difference in sensitivity of mice to renal toxicity of inorganic mercury. J Pharmacol Exp Ther 285: 335-341, 1998
19. Zalups RK: Molecular interactions with mercury in the kidney. Pharmacol Rev 52: 113-143, 2000
20. Diamond GL, Zalups RK: Understanding renal toxicity of heavy metals. Toxicol Pathol 26: 92-103, 1998
21. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, et al.: Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science 269: 230-234, 1995
22. Keegan BP, Sheflin LG, Spaulding SW: The internalization and endosomal trafficking of the EGF receptor in response to EGF is delayed in the waved-2 mouse liver. Biochem Biophys Res Commun 267: 881-886, 2000
23. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR: Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73: 249-261, 1993
24. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC: TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice, Cell 73: 263-278, 1993
25. Berkowitz EA, Seroogy KB, Schroeder JA, Russell WE, Evans EP, Riedel RF, Phillips HK, Harrison CA, Lee DC, Luetteke NC: Characterization of the mouse transforming growth factor alpha gene: Its expression during eyelid development and in waved 1 tissues. Cell Growth Differ 7: 1271-1282, 1996
26. Breyer MD, Redha R, Breyer JA: Segmental distribution of epidermal growth factor binding sites in rabbit nephron. Am J Physiol 259: F553-F558, 1990
27. Harris RC, Daniel TO: Epidermal growth factor binding, stimulation of phosphorylation, and inhibition of gluconeogenesis in rat proximal tubule. J Cell Physiol 139: 383-391, 1989
28. Safirstein R, Price PM, Saggi SJ, Harris RC: Changes in gene expression after temporary renal ischemia. Kidney Int 37: 1515-1521, 1990
29. Behrens MT, Corbin AL, Hise MK: Epidermal growth factor receptor regulation in the rat kidney: Two models of renal growth. Am J Physiol 257: F1059-F1065, 1989
30. Coimbra TM, Cieslinski DA, Humes HD: Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 259: F438-F443, 1990
31. Cohen S: Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 237: 1555-1562, 1962
32. Carpenter GCS: Epidermal growth factor. Ann Rev Biochem 48: 193-230, 1979
33. Rall LB, Scott J, Bell GI, Crawford RJ, Penshcow JD, Niall HD, Coghlan JP: Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 313: 228, 1985
34. Verstrepen WA, Nouwen EJ, Zhu MQ, Ghielli M, De Broe ME: Time course of growth factor expression in mercuric chloride acute renal failure. Nephrol Dial Transplant 10: 1361-1371, 1995
35. Schaudies RP, Johnson JP: Increased soluble EGF after ischemia is accompanied by a decrease in membrane-associated precursors. Am J Physiol 264: F523-F531, 1993
36. Witzgall R, Brown D, Schwarz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney, Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93: 2175-2188, 1994
37. Goodyer PR, Fata J, Mulligan L, Fischer D, Fagan R, Guyda HJ, Goodyer CG: Expression of transforming growth factor-alpha and epidermal growth factor receptor in human fetal kidneys. Mol Cell Endocrinol 77: 199-206, 1991
38. Cybulsky AV, Goodyer PR, McTavish AJ: Epidermal growth factor receptor activation in developing rat kidney. Am J Physiol 267: F428-F436, 1994
39. Takemura T, Hino S, Okada M, Murata Y, Yanagida H, Ikeda M, Yoshioka K, Harris RC: Role of membrane-bound heparin-binding epidermal growth factor-like growth factor (HB-EGF) in renal epithelial cell branching. Kidney Int 61: 1968-1979, 2002
40. Rogers SA, Ryan G, Hammerman MR: Metanephric transforming growth factor-alpha is required for renal organogenesis in vitro. Am J Physiol 262: F533-F539, 1992
41. Pugh JL, Sweeney WE Jr, Avner ED: Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. Kidney Int 47: 774-781, 1995
42. Takemura T, Hino S, Kuwajima H, Yanagida H, Okada M, Nagata M, Sasaki S, Barasch J, Harris RC, Yoshioka K: Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor. J Am Soc Nephrol 12: 964-972, 2001
43. Coles HS, Burne JF, Raff MC: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118: 777-784, 1993
44. Koseki C, Herzlinger D, al-Awqati Q: Apoptosis in metanephric development. J Cell Biol 119: 1327-1333, 1992
45. Takemura T, Kondo S, Homma T, Sakai M, Harris RC: The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells. J Biol Chem 272: 31036-31042, 1997
46. Takemura T, Hino S, Murata Y, Yanagida H, Okada M, Yoshioka K, Harris RC: Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability. Kidney Int 55: 71-81, 1999